首页> 外文期刊>Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases >Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique.
【24h】

Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique.

机译:肝素钠缺乏使用抗生素锁定技术治疗因金黄色葡萄球菌引起的实验性导管相关感染的抗微生物活性。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To elucidate the potential antimicrobial activity of sodium heparin in the treatment of catheter-infection using the antibiotic-lock technique. METHODS: We performed in vitro studies of the antibiotic susceptibility, stability and synergy of sodium heparin, vancomycin and ciprofloxacin. Efficacy studies were performed in a new animal model of Staphylococcus aureus catheter-related infection in which infection was produced via the endoluminal route. White New Zealand rabbits were surgically implanted with a sylastic catheter into the inferior cava vein. Immediately afterwards, infection was induced by filling and locking the catheters with 0.7 mL of broth culture containing 108 colony-forming units of S. aureus. Eighteen hours later the antibiotic-lock technique was started. Treatment groups were: control without treatment, sodium heparin at 2500 IU/mL, vancomycin at 2500 mg/L, ciprofloxacin at 1000 mg/L, vancomycin plus heparin and ciprofloxacin plus heparin. RESULTS: Sodium heparin showed an MIC90 higher than 6000 UI/mL against S. aureus causing catheter infection. Studies of antimicrobial synergy by the time-kill method between vancomycin and ciprofloxacin at MIC with sodium heparin at 2500 IU/mL showed no interactions. Vancomycin (2000 microg/mL) and ciprofloxacin (1000 microg/mL) in a solution containing sodium heparin (2500 IU/mL) were stable at 37 degrees C for a 72-h period. Two sets of in vivo experiments were carried out using differents strains of S. aureus. In both cases, sodium heparin showed no therapeutic efficacy when compared to control group and did not increase the antibiotic efficacy when used in combination with vancomycin or ciprofloxacin. CONCLUSION: Sodium heparin lacked antibacterial activity against S. aureus causing catheter-related infections.
机译:目的:阐明使用抗生素锁定技术的肝素钠在导管感染治疗中的潜在抗菌活性。方法:我们对肝素钠,万古霉素和环丙沙星的抗生素敏感性,稳定性和协同作用进行了体外研究。在金黄色葡萄球菌导管相关感染的新动物模型中进行了功效研究,其中感染是通过腔内途径产生的。将白色新西兰兔用回弹导管经外科手术植入下腔静脉。此后,立即通过用0.7 mL含有108个金黄色葡萄球菌集落形成单位的肉汤培养物填充并锁定导管来诱导感染。 18小时后,开始使用抗生素锁定技术。治疗组为:未经治疗的对照组,2500 IU / mL的肝素钠,2500 mg / L的万古霉素,1000 mg / L的环丙沙星,万古霉素加肝素和环丙沙星加肝素。结果:肝素钠对金黄色葡萄球菌引起的导管感染的MIC90高于6000 UI / mL。万古霉素和环丙沙星在MIC和2500 IU / mL肝素钠作用下通过时间杀灭方法进行的抗菌协同作用研究显示没有相互作用。在含有肝素钠(2500 IU / mL)的溶液中,万古霉素(2000微克/毫升)和环丙沙星(1000微克/毫升)在37摄氏度下稳定72小时。使用金黄色葡萄球菌的不同菌株进行了两组体内实验。在两种情况下,与对照组相比,肝素钠均无治疗效果,与万古霉素或环丙沙星合用时,其肝素作用未增加。结论:肝素钠缺乏对金黄色葡萄球菌引起的导管相关感染的抗菌活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号